Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Mar 22, 2022

SELL
$14.7 - $28.67 $999,600 - $1.95 Million
-68,000 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$24.31 - $33.6 $1.65 Million - $2.28 Million
68,000 New
68,000 $1.93 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Ascendant Capital Management, LLC Portfolio

Follow Ascendant Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascendant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascendant Capital Management, LLC with notifications on news.